Amir Ali Talasaz is Co-Chief Executive Officer of Guardant Health, Inc.. Currently has a direct ownership of 2.19 Million shares of GH, which is worth approximately $59.4 Million. The most recent transaction as insider was on May 02, 2024, when has been sold 283,830 shares (Common Stock) at a price of $4.18 per share, resulting in proceeds of $1,186,409. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.19M
15.29% 3M change
15.29% 12M change
Total Value Held $59.4 Million

AmirAli Talasaz Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2024
BUY
Exercise of conversion of derivative security
$1,186,409 $4.18 p/Share
283,830 Added 11.46%
2,193,127 Common Stock
Mar 31 2024
SELL
Payment of exercise price or tax liability
$93,020 $20.63 p/Share
4,509 Reduced 0.24%
1,909,297 Common Stock
Mar 31 2024
BUY
Exercise of conversion of derivative security
-
11,461 Added 0.6%
1,913,806 Common Stock
Mar 14 2023
BUY
Open market or private purchase
$224,400 $26.4 p/Share
8,500 Added 0.44%
1,902,345 Common Stock
Mar 13 2023
BUY
Open market or private purchase
$1,016,400 $25.41 p/Share
40,000 Added 2.07%
1,893,845 Common Stock
Nov 23 2021
BUY
Open market or private purchase
$5,175,865 $94.97 p/Share
54,500 Added 2.86%
1,853,845 Common Stock
Nov 19 2021
BUY
Open market or private purchase
$4,915,000 $98.3 p/Share
50,000 Added 2.7%
1,799,345 Common Stock
Aug 13 2021
BUY
Exercise of conversion of derivative security
$99,998 $4.18 p/Share
23,923 Added 1.35%
1,749,345 Common Stock
Feb 11 2021
SELL
Open market or private sale
$33,622,207 $166.24 p/Share
202,251 Reduced 10.49%
1,725,422 Common Stock
Feb 10 2021
SELL
Open market or private sale
$9,329,223 $160.01 p/Share
58,304 Reduced 2.94%
1,927,673 Common Stock
Feb 09 2021
SELL
Open market or private sale
$16,504,348 $163.23 p/Share
101,111 Reduced 4.85%
1,985,632 Common Stock
Feb 08 2021
SELL
Open market or private sale
$15,082,665 $162.69 p/Share
92,708 Reduced 4.25%
2,086,743 Common Stock
Feb 05 2021
SELL
Open market or private sale
$32,418,878 $160.6 p/Share
201,861 Reduced 8.48%
2,179,451 Common Stock
Feb 04 2021
SELL
Open market or private sale
$7,483,780 $159.05 p/Share
47,053 Reduced 1.94%
2,381,312 Common Stock
Feb 03 2021
SELL
Open market or private sale
$12,209,488 $158.74 p/Share
76,915 Reduced 3.07%
2,428,365 Common Stock
Feb 02 2021
SELL
Open market or private sale
$20,648,371 $157.75 p/Share
130,893 Reduced 4.75%
2,622,883 Common Stock
Feb 01 2021
SELL
Open market or private sale
$14,798,192 $154.56 p/Share
95,744 Reduced 3.36%
2,753,776 Common Stock
Jan 06 2021
SELL
Payment of exercise price or tax liability
$36,158,110 $129.54 p/Share
279,127 Reduced 8.92%
2,849,520 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
565,192 Added 15.3%
3,128,647 Common Stock
Dec 27 2020
SELL
Bona fide gift
-
25,000 Reduced 0.99%
2,505,280 Common Stock
Dec 21 2020
BUY
Exercise of conversion of derivative security
$99,998 $4.18 p/Share
23,923 Added 0.92%
2,563,455 Common Stock
Dec 02 2020
SELL
Bona fide gift
-
92,603 Reduced 3.53%
2,530,280 Common Stock
AT

Amir Ali Talasaz

Co-Chief Executive Officer
Redwood City, CA

Track Institutional and Insider Activities on GH

Follow Guardant Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

News

Receive news related to Guardant Health, Inc.

Track Activities on GH